journal article·2009-06

Morphological analysis of the antimicrobial action of nitric oxide on Gram-negative pathogens using atomic force microscopy

Susan M. Deupree, Mark H. Schoenfisch

Acta Biomaterialia· Volume 5· Issue 5
Publisher page

Abstract

Atomic force microscopy (AFM) was used to study the morphological changes of two gram-negative pathogens, Pseudomonas aeruginosa and Escherichia coli, after exposure to nitric oxide (NO). The time-dependent effects of NO released from a xerogel coating and the concentration-dependent effects rendered by a small molecule that releases NO in a bolus were examined and compared. Bacteria exhibited irregular and degraded exteriors. With NO-releasing surfaces, an increase in surface debris and disorganized adhesion patterns were observed compared to controls. Analysis of cell surface topography revealed that increasing membrane roughness correlated with higher doses of NO. At a lower total dose, NO delivered via a bolus resulted in greater membrane roughness than NO released from a surface via a sustained flux. At sub-inhibitory levels, treatment with amoxicillin, an antibiotic known to compromise the integrity of the cell wall, led to morphologies resembling those resulting from NO treatment. Our observations indicate that cell envelope deterioration is a visible consequence of NO-exposure for both gram-negative species studied.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Inhalation and Respiratory Drug Delivery · Polymer Surface Interaction Studies · Force Microscopy Techniques and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Nitric oxide: a physiologic messenger10.7326/0003-4819-120-3-199402010-00009 ↗
2. Nitric oxide and the immune response10.1038/ni1001-907 ↗
3. Therapeutic potential of nitric oxide in cancer10.1016/j.drup.2006.05.003 ↗
4. Buga · 2000
5. Reduced foreign body response at nitric oxide-releasing subcutaneous implants10.1016/j.biomaterials.2007.06.036 ↗
6. Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates10.1146/annurev.pharmtox.43.100901.135831 ↗
7. Nitric oxide-releasing drugs10.1146/annurev.pharmtox.43.100901.140226 ↗
8. Nitric oxide-releasing polymers containing the [N(O)NO]-group10.1021/jm950652b ↗
9. The chemistry of S-nitrosothiols10.1021/ar9800439 ↗
10. Chemistry, analysis, and biological rolse of S-nitrosothiols10.1006/abio.1997.2129 ↗
11. Synthesis of nitric oxide-releasing silica nanoparticles10.1021/ja0674338 ↗
12. Inorganic/organic hybrid silica nanoparticles as a nitric oxide delivery scaffold10.1021/cm702526q ↗
13. Preparation of nitric oxide (NO)-releasing sol–gels for biomaterial applications10.1021/cm034347n ↗
14. Synthesis and characterization of nitric oxide-releasing sol–gel microarrays10.1021/la048368n ↗
15. Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor10.1021/jm960616s ↗
16. New nitric oxide-releasing zwitterions derived from polyamines10.1021/jo00058a030 ↗
17. Nitric oxide contributes to induction of innate immune responses to Gram-negative bacteria in Drosophila10.1101/gad.1018503 ↗
18. Nitric oxide and macrophage function10.1146/annurev.immunol.15.1.323 ↗
19. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide10.1016/S0891-5849(98)00092-6 ↗
20. Mechanisms of nitric oxide-related antimicrobial activity10.1172/JCI119473 ↗
21. Acceleration of nitric oxide autooxidation and nitrosation by membranes
22. Nitric oxide-induced nitrative stress involved in microbial pathogenesis10.1254/jphs.CRJ05004X ↗
23. Potential application of gaseous nitric oxide as a topical antimicrobial agent10.1016/j.niox.2005.08.003 ↗
24. Sol–gel derived nitric-oxide releasing materials that reduce bacterial adhesion10.1021/ja0165077 ↗
25. Nitric oxide-releasing sol–gels as antibacterial coatings for orthopedic implants10.1016/j.biomaterials.2004.03.031 ↗
26. Antibacterial properties of nitric oxide-releasing sol–gels10.1002/jbm.a.20030 ↗
27. Antibacterial nitric oxide-releasing xerogels: cell viability and parallel plate flow cell adhesion studies10.1016/j.biomaterials.2007.01.006 ↗
28. Hetrick EM, Shin JH, Stasko NA, Johnson BA, Wespe DA, Holmuhamedov E, Schoenfisch MH. Bactericidal efficacy of nitric oxide-releasing silica nanoparticles. ACS Nano 2007;2(235-246).10.1021/nn700191f ↗
29. Morphological expression of antibiotic synergism against Pseudomonas aeruginosa as observed by scanning electron microscopy10.1128/AAC.18.6.969 ↗
30. Effect of the inhibition of protein synthesis on the Escherichia coli cell envelope10.1128/AAC.6.2.216 ↗
31. Cell wall alterations of Gram-negative bacteria by aminoglycoside antibiotics10.1128/AAC.5.1.95 ↗
32. Effects of the antimicrobial peptide PGLa on live Escherichia coli10.1016/j.bbamcr.2003.10.001 ↗
33. Atomic force microscopy study of the antimicrobial action of Sushi peptides on Gram-negative bacteria10.1016/j.bbamem.2006.12.010 ↗
34. Atomic force microscopy study of the effect of antimicrobial peptides on the cell envelope of Escherichia coli10.1128/AAC.49.10.4085-4092.2005 ↗
35. Atomic force microscopy study of the antibacterial effects of chitosans on Escherichia coli and Staphylococcus aureus10.1016/j.ultramic.2008.04.015 ↗
36. Mechanism of antimicrobial activity of CdTe quantum dots10.1021/la704075r ↗
37. Atomic force microscopy study of different effects of natural and semisynthetic β-lactam on the cell envelope of Escherichia coli10.1021/ac0604890 ↗
38. Quantitative method for determining the lateral strength of bacterial adhesion and application for characterizing adhesion kinetics10.1021/la800417g ↗
39. Activities of β-lactams, fluoroquinolones, amikacin, and fosfomycin alone and in combination against Pseudomonas aeruginosa isolated from complicated urinary tract infections10.1007/s101560050022 ↗
40. Role for the Salmonella flavohemoglobin in protection from nitric oxide10.1074/jbc.273.20.12543 ↗
41. Activation by nitric oxide of an oxidative-stress response that defends Escherichia coli against activated macrophages10.1073/pnas.90.21.9993 ↗
42. Nitrosative stress: activation of the transcription factor OxyR10.1016/S0092-8674(00)80147-6 ↗
43. Nitrosative stress: Metabolic pathway involving the flavohemoglobin10.1073/pnas.95.24.14100 ↗